Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Radiation Oncology (London, England)|January 14, 2021
Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [18F]FDG PET and CT perfusion: a prospective exploratory clinical studyDae-Myoung Yang, David A Palma, Keith Kwan, et al.JAMA Oncology|February 22, 2019
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical TrialDavid A Palma, Timothy K Nguyen, Alexander V Louie, et al.International Journal of Radiation Oncology, Biology, Physics|June 1, 2022
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term OutcomesStephen Harrow, David A Palma, Robert Olson, et al.BMC Cancer|May 7, 2020
Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trialRobert Olson, Lindsay Mathews, Mitchell Liu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2020
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized TrialDavid A Palma, Robert Olson, Stephen Harrow, et al.BMC Cancer|August 21, 2019
Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trialDavid A Palma, Robert Olson, Stephen Harrow, et al.Pageof 2